Clinical factors associated with the outcome of oocyte donation;Facteurs cliniques et résultats du don d'ovocytes

Gynecologie Obstetrique et Fertilite

Volumn 35, Issue 10, 2007, Pages 1015-1023

  Vernaeve, V ^a   Reis Soares, S ^b   Budak, E ^a   Bellver, J ^a   Remohi, J ^a   Pellicer, A ^a  

^a INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

^b Instituto Valenciano de Infertilidad (IVI) Lisboa   (Portugal)

Author keywords

Assisted reproductive techniques (ART); Endometrial receptivity; Hormone replacement therapy; Oocyte donation; Predictive factors; Recipient uterine age

Indexed keywords

ESTRADIOL;

BODY MASS; CIGARETTE SMOKING; ENDOMETRIOSIS; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; HUMAN; HYDROSALPINX; OOCYTE DONATION; PREGNANCY RATE; SHORT SURVEY; TOBACCO DEPENDENCE; BLOOD; ENDOMETRIUM; FEMALE; PHYSIOLOGY; PREGNANCY; PREGNANCY OUTCOME; REVIEW; SMOKING; STATISTICS;

BODY MASS INDEX; ENDOMETRIOSIS; ENDOMETRIUM; ESTRADIOL; FEMALE; HUMANS; OOCYTE DONATION; PREGNANCY; PREGNANCY OUTCOME; SMOKING;

EID: 35348863006     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2007.06.016     Document Type: Short Survey

References (60)

1. Andersen A.N., Gianaroli L., Felderbaum R., de Mouzon J., and Nygren K.G. The European IVF-monitoring programme (EIM), European Society of Human Reproduction and Embryology (ESHRE). Assisted reproductive technology in Europe, 2001. Results generated from European registers by ESHRE. Hum. Reprod. 20 (2005) 1158-1176
2. Remohi J., Gutierrez A., Cano F., Simon C., and Pellicer A. Long estradiol replacement in an oocyte donation programme. Hum. Reprod. 6 (1995) 1387-1391
3. Remohi J., Gartner B., Gallardo E., Yalil S., Simon C., and Pellicer A. Pregnancy and birth rates after oocyte donation. Fertil. Steril. 67 (1997) 717-723
4. Budak E., Garrido N., Soares S.R., Melo M.A., Meseguer M., Pellicer A., et al. Improvements achieved in an oocyte donation program over a 10-year period: sequential increase in implantation and pregnancy rates and decrease in high-order multiple pregnancies. Fertil. Steril. 88 (2007) 342-349
5. Yaron Y., Ochshorn Y., Amit A., Kogosowski A., Yovel I., and Lessing J.B. Oocyte donation in Israel: a study of 1001 initiated treatment cycles. Hum. Reprod. 13 (1998) 1819-1824
6. Moomjy M., Cholst I., Mangieri R., and Rosenwaks Z. Oocyte donation: insights into implantation. Fertil. Steril. 71 (1999) 15-21
7. Cano F., Simón C., Remohí J., and Pellicer A. Effect of aging on the female reproductive system: evidence for a role of uterine senescence in the decline in female fecundity. Fertil. Steril. 64 (1995) 584-589
8. Noyes N., Hampton B.S., Berkeley A., Licciardi F., Grifo J., and Krey L. Factors useful in predicting the success of oocyte donation: a 3-year retrospective analysis. Fertil. Steril. 76 (2001) 92-97
9. Toner J.P., Grainger D.A., and Frazier L.M. Clinical outcomes among recipients of donated eggs: an analysis of the US national experience, 1996-1998. Fertil. Steril. 78 (2002) 1038-1045
10. Soares S.R., Troncoso C., Bosch E., Serra V., Simon C., Remohí J., et al. Age and uterine receptiveness: predicting the outcome of oocyte donation cycles. J. Clin. Endocrinol. Metab. 90 (2005) 4399-4404
11. Söderström-Anttila V. Pregnancy and child outcome after oocyte donation. Hum. Reprod. Update 7 (2001) 28-32
12. Simchen M.J., Yinon Y., Moran O., Schiff E., and Sivan E. Pregnancy outcome after age 50. Obstet. Gynecol. 108 (2006) 1084-1088
13. Nichols J.E., Crane M.M., Higdon H.L., Miller P.B., and Boone W.R. Extremes of body mass index reduces in vitro fertilization pregnancy rates. Fertil. Steril. 79 (2003) 645-647
14. Fedorcsak P., Dale P.O., Storeng R., Ertzeid G., Bjercke S., Oldereid N., et al. Impact of overweight and underweight on assisted reproduction treatment. Hum. Reprod. 19 (2004) 2523-2528
15. Wattanakumtornkul S., Damario M.A., Stevens Hall S.A., Thornhill A.R., and Tummon I.S. Body mass index and uterine receptivity in the oocyte donation model. Fertil. Steril. 80 (2003) 336-340
16. Styne-Gross A., Elkind-Hirsch K., and Scott Jr. R.T. Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation. Fertil. Steril. 83 (2005) 1629-1634
17. Li T.C., Spuijbroek M.D., Tuckerman E., Anstie B., Loxley M., and Laird S. Endocrinological and endometrial factors in recurrent miscarriage. BJOG 107 (2000) 1471-1479
18. Bellver J., Rossal L.P., Bosch E., Zúñiga A., Corona J.T., Meléndez F., et al. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil. Steril. 79 (2003) 1136-1140
19. Simon C., Guttierez A., Vidal A., De los Santos M.J., Remohi J., and Pellicer A. Outcome of patients with endometriosis in assisted reproduction: results from in vitro fertilization and oocyte donation. Hum. Reprod. 9 (1994) 725-729
20. Kuivasaari P., Hippeläinen M., Anttila M., and Heinonen S. Effect of endometriosis on IVF-ICSI outcome: stage III-IV endometriosis worsens cumulative pregnancy and live-born rates. Hum. Reprod. 20 (2005) 3130-3135
21. Diaz I., Navarro J., Blasco L., Simon C., Pellicer A., and Remohi J. Impact of stage III-IV endometriosis on recipients of sibling oocytes: matched case-control study. Fertil. Steril. 74 (2000) 31-34
22. Camus E., Poncelet C., Goffinet F., Wainer B., Merlet F., Nisand I., et al. Pregnancy rates after in vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies. Hum. Reprod. 14 (1999) 1243-1249
23. Strandell A., Lindhard A., Waldenström U., Thoburn J., Janson P.O., and Hamberger L. Hydrosalpinx and IVF outcome: a prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF. Hum. Reprod. 14 (1999) 2762-2769
24. Stadtmauer L.A., Riehl R.M., Toma S.K., and Talbert L.M. Cauterization of hydrosalpinges before in vitro fertilization is an effective surgical treatment associated with improved pregnancy rates. Am. J. Obstet. Gynecol. 183 (2000) 367-371
25. Johnson N.P., Mak W., and Sowter M.C. Surgical treatment for tubal disease in women due to undergo in vitro fertilization. Cochrane Database Syst. Rev. 3 (2004) (CD002125)
26. Kontoravdis A., Makrakis E., Pantos K., Botsis D., Deligeoroglou E., and Creatsas G. Proximal tubal occlusion and salpingectomy result in similar improvement in in vitro fertilization outcome in patients with hydrosalpinx. Fertil. Steril. 86 (2006) 1642-1649
27. Hurst B.S., Tucker K.E., Awoniyi C.A., and Schlaff W.D. Hydrosalpinx treated with extended doxycycline does not compromise the success of in vitro fertilization. Fertil. Steril. 75 (2001) 1017-1019
28. Augood C., Duckitt K., and Templeton A.A. Smoking and female infertility: a systematic review and meta-analysis. Hum. Reprod. 13 (1998) 1532-1539
29. Mailhes J.B., Young D., Caldito G., and London S.N. Sensitivity of mouse oocytes to nicotine-induced perturbations during oocyte meiotic maturation and aneuploidy in vivo and in vitro. Mol. Hum. Reprod. 6 (2000) 232-237
30. Jick H., Porter J., and Morrison A.S. Relation between smoking and age of natural menopause. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet 309 (1977) 1354-1355
31. Klonoff-Cohen H., Natarajan L., Marrs R., and Yee B. Effects of female and male smoking on success rates of IVF and gamete intra-Fallopian transfer. Hum. Reprod. 16 (2001) 1382-1390
32. Neal M.S., Hughes E.G., Holloway A.C., and Foster W.G. Sidestream smoking is equally as damaging as mainstream smoking on IVF outcomes. Hum. Reprod. 20 (2005) 2531-2535
33. Soares S.R., Simon C., Remohi J., and Pellicer A. Cigarette smoking affects uterine receptiveness. Hum. Reprod (2007) 543-547
34. Olsen J., Bonnelykke B., and Nielsen J. Tobacco smoking and twinning. Acta Med. Scand. 224 (1998) 491-494
35. Garcia-Velasco J.A., Isaza V., Caligara C., Pellicer A., Remohi J., and Simon C. Factors that determine discordant outcome from shared oocytes. Fertil. Steril. 80 (2003) 54-60
36. Borini A., Bianchi L., Violini F., Maccolini A., Cattoli M., and Flamigni C. Oocyte donation program: pregnancy and implantation rates in women of different ages sharing oocytes from single donor. Fertil. Steril. 65 (1996) 94-97
37. Remohí J., Ardiles G., García-Velasco J.A., Gaitan P., Simón C., and Pellicer A. Endometrial thickness and serum estradiol concentrations as predictors of outcome in oocyte donation. Hum. Reprod. 12 (1997) 2271-2276
38. Letur-Konirsch H., and Delanian S. Successful pregnancies after combined pentoxifylline-tocopherol treatment in women with premature ovarian failure who are resistant to hormone replacement therapy. Fertil. Steril. 79 (2003) 439-441
39. Friedler S., Schenker J.G., Herman A., and Lewin A. The role of ultrasonography in the evaluation of endometrial receptivity following assisted reproductive treatments: a critical review. Hum. Reprod. Update 2 (1996) 323-335
40. Lutjen P., Trounson A., Leeton J., Findlay J., Wood C., and Renou P. The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature 307 (1984) 174-175
41. Remohí J., Gallardo E., Guanes P.P., Simón C., and Pellicer A. Donor-recipient synchronization and the use of gonadotrophin-releasing hormone agonists to avoid the premature luteinizing hormone surge in oocyte donation. Hum. Reprod. 10 Suppl 2 (1995) 84-90
42. Michalas S., Loutradis D., Drakakis P., Kallianidis K., Milingos S., Deligeoroglou E., et al. A flexible protocol for the induction of recipient endometrial cycles in an oocyte donation programme. Hum. Reprod. 11 (1996) 1063-1066
43. Yaron Y., Amit A., Mani A., Yovel I., Kogosowski A., Peyser M.R., et al. Uterine preparation with estrogen for oocyte donation: assessing the effect of treatment duration on pregnancy rates. Fertil. Steril. 63 (1995) 1284-1286
44. Younis J.S., Mordel N., Lewin A., Simon A., Schenker J.G., and Laufer N. Artificial endometrial preparation for oocyte donation: the effect of estrogen stimulation on clinical outcome. J. Assist. Reprod. Genet. 9 (1992) 222-227
45. Borini A., Del Prato L., Bianchi L., Violini F., Cattoli M., and Flamigni C. Effect of duration of estradiol replacement on the outcome of oocyte donation. J. Assist. Reprod. Genet. 18 (2001) 185-190
46. Devroey P., and Pados G. Preparation of endometrium for egg donation. Hum. Reprod. Update 4 (1998) 856-861
47. Tourgeman D.E., Gentzchein E., Stanczyk F.Z., and Paulson R.J. Serum and tissue hormone levels of vaginally and orally administered estradiol. Am. J. Obstet. Gynecol. 180 (1999) 1480-1483
48. Lewin A., Pisov G., Turgeman R., Fatum M., Shufaro Y., Simon A., et al. Simplified artificial endometrial preparation, using oral estradiol and novel vaginal progesterone tablets: a prospective randomized study. Gynecol. Endocrinol. 16 (2002) 131-136
49. Dmowski W.P., Michalowska J., Rana N., Friberg J., McGill-Johnson E., and DeOrio L. Subcutaneous estradiol pellets for endometrial preparation in donor oocyte recipients with a poor endometrial response. J. Assist. Reprod. Genet. 14 (1997) 139-144
50. Devroey P., Palermo G., Bourgain C., Van Waesberghe L., Smitz J., and Van Steirteghem A.C. Progesterone administration in patients with absent ovaries. Int. J. Fertil. 34 (1989) 188-193
51. Tavaniotou A., Smitz J., Bourgain C., and Devroey P. Comparison between different routes of progesterone administration as luteal phase support in infertility treatments. Hum. Reprod. Update 6 (2000) 139-148
52. Miles R.A., Paulson R.J., Lobo R.A., Press M.F., Dahmoush L., and Sauer M.V. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertil. Steril. 62 (1994) 485-490
53. Daya S., and Gunby J. Luteal phase support in assisted reproduction cycles. Cochrane Database Syst. Rev. 3 (2004) (CD004830)
54. Manno M., Marchesan E., Cicutto D., Zadro D., Favretti C., and Tomei F. Greater implantation and pregnancy rates with vaginal progesterone in intracytoplasmic sperm injection but not in in vitro fertilization cycles: a retrospective study. Fertil. Steril. 83 (2005) 1391-1396
55. Lightman A., Kol S., and Itskovitz-Eldor J. A prospective randomized study comparing intramuscular with intravaginal natural progesterone in programmed thaw cycles. Hum. Reprod. 14 (1999) 2596-2599
56. Gibbons W.E., Toner J.P., Hamacher P., and Kolm P. Experience with a novel vaginal progesterone preparation in a donor oocyte program. Fertil. Steril. 69 (1998) 96-101
57. Navot D., Anderson T.L., Droesch K., Scott R.T., Kreiner D., and Rosenwaks Z. Hormonal manipulation of endometrial maturation. J. Clin. Endocrinol. Metab. 68 (1989) 801-807
58. Simon A., Hurwitz A., Zentner B.S., Bdolah Y., and Laufer N. Transfer of frozen-thawed embryos in artificially prepared cycles with and without prior gonadotrophin-releasing hormone agonist suppression: a prospective randomized study. Hum. Reprod. 13 (1998) 2712-2717
59. Dal Prato L., Borini A., Cattoli M., Bonu M.A., Sciajno R., and Flamigni C. Endometrial preparation for frozen-thawed embryo transfer with or without pretreatment with gonadotropin-releasing hormone agonist. Fertil. Steril. 77 (2002) 956-960
60. El-Toukhy T., Taylor A., Khalaf Y., Al-Darazi K., Rowell P., Seed P., et al. Pituitary suppression in ultrasound-monitored frozen embryo replacement cycles. A randomized study. Hum. Reprod. 19 (2004) 874-879